Blood Cancer United

Blood Cancer United is a Rye Brook, New York-based nonprofit 501(c)(3) and foundation-style capital provider funding blood cancer research and patient-focused oncology initiatives. It has invested more than $2 billion in research and is relevant for life sciences, biotechnology and oncology companies, including later-stage venture therapeutics aligned with blood cancer. Its investment geography spans the United States and global research activity.